Health products policy and standards
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure good practice throughout the value chain.
Highlights
/health-product-policy-and-standards-(hps)/63022.jpg?sfvrsn=e93c78d1_9 "Ministry of Health staff at their office in Port Vila")
/health-product-policy-and-standards-(hps)/who_034416-sm.jpg?sfvrsn=fc08f9ca_4 "WHO_034416 sm")
/health-product-policy-and-standards-(hps)/70820.jpg?sfvrsn=6b0fda4c_1 "70820")
Expert Committees
Advisory groups
Databases
Publications
All →
1 December 2025
Assistive technology progress assessment questionnaire: tracking progress on access to assistive technology
In May 2018, the World Health Assembly (WHA) adopted resolution WHA71.8 on improving access to assistive technology. The resolution urges Member States...
12 November 2025
Development of medical device policies, 2nd ed.
A first edition of the Development of Medical Devices Policies was published in 2011. This second edition was prepared to reflect the transition from the...
6 October 2025
Improving access to assistive technology in United Republic of Tanzania (2022-2023): project report
The report summarizes a collaboration between the Ministry of Health of the United Republic of Tanzania, HelpAge Tanzania and the World Health Organization...
5 October 2025
Enabling rapid access to essential assistive technology in Ukraine (2022-2023): project report
This report summarizes a collaboration between the Ministry of Health of Ukraine and the World Health Organization (WHO) in 2022 and 2023. The goal was...
Journal articles
Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool
Pharmaceutics. 2022 Feb 22;14(3):473
The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
Front Pharmacol. 2020 Sep 11;11:578000
WHO's essential medicines and AWaRe: recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections
Clinical Microbiology and Infection 30 (2024) S1eS51
